Gilberto Lopes Júnior

35PUBLICATIONS
267CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsPacific Peoples sport and physical activityPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jun 11, 2026
Geographic, Temporal, and Sex-Specific Trends in Mesothelioma Burden in the United States, 1990-2023.

|Apr 13, 2026
Cost comparison of osimertinib plus platinum-pemetrexed versus amivantamab plus lazertinib for the first-line treatment of patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer.

Gilberto de Lima Lopes, Harry Freeman, Emily Procter

|Mar 26, 2026
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.

Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano

|Mar 26, 2026
Exercise Counseling and Referral Practices Among Oncology Care Physicians in Latin America: A Multinational Survey Study.

Paulo Gustavo Bergerot, Cristiane Decat Bergerot, Errol J Philip

|Dec 19, 2025
Cost-Effectiveness Analysis of Durvalumab in Limited-Stage Small Cell Lung Cancer in the United States.

Chinmay T Jani, Aysswarya Manoharan, Sunwoo Han

|Nov 19, 2025
Premature Deaths and Life-Years Lost From Lack of Amivantamab in Brazil's Unified Health System.

Gabriel Lenz, Rafael Alvim Pereira, Wallace Klein Schwengber

Pageof 6

Frequent Collaborators

4 joint publications

Narjust Florez

3 joint publications

Estelamari Rodriguez

3 joint publications

Maria T Bourlon

3 joint publications

Samuel Kareff